Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
Würzburg University Clinic, Würzburg, Germany
wanner_c@ukw.de
Christoph
Ch
Wanner
Yale University School of Medicine, New Haven, CT
Silvio E
SE
Inzucchi
University of Toronto, Toronto, ON, Canada
Bernard
B
Zinman
D001786:Blood Glucose; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005960:Glucosides / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007674:Kidney Diseases / Q000188:drug therapy; D051297:Sodium-Glucose Transporter 2
D001786:Blood Glucose; D005960:Glucosides; D007004:Hypoglycemic Agents; D051297:Sodium-Glucose Transporter 2